Epidiolex, the first FDA-approved plant-derived CBD medication, significantly reduces seizures in Dravet and Lennox-Gastaut syndromes but has important side effects and drug interactions that require careful management.
Parents of children with refractory epilepsy, neurologists, and pharmacists.
First FDA-approved plant-derived CBD medication
What the researchers found
Epidiolex was FDA-approved June 2018 for patients aged 2+ with Dravet or Lennox-Gastaut syndrome. Common side effects include somnolence, decreased appetite, and diarrhea. Significant drug interactions occur with clobazam (increased active metabolite levels) and valproate (hepatotoxicity risk). CBD is metabolized primarily by CYP3A4 and CYP2C19, creating numerous potential interactions with other antiepileptic drugs.
Why it matters
Patients with Dravet and Lennox-Gastaut syndromes have limited treatment options. Understanding both the benefits and the interaction risks of Epidiolex is essential for safe prescribing.
The numbers in context
FDA approved June 25, 2018. Approved for ages 2+. Metabolized by CYP3A4 and CYP2C19. Significant interactions with clobazam and valproate.
How the study worked
State-of-the-art review covering CBD history, pharmacology, toxicology, clinical evidence, side effects, and drug-drug interactions in epilepsy.
What this study cannot tell us
Limited long-term efficacy and safety data. Drug interaction studies are ongoing. Review reflects knowledge at time of publication.
How to read the evidence
Comprehensive review of randomized controlled trial data supporting FDA approval.
When this study was published
2020 review of product approved in 2018.
The bigger picture
As the first plant-derived CBD product with FDA approval, Epidiolex bridges the gap between medical cannabis and conventional pharmaceuticals, but its complex interactions highlight the importance of pharmaceutical oversight.
Questions still open
- Will long-term CBD use in children reveal new safety concerns? Can dosing strategies minimize hepatotoxicity risk when combined with valproate?
Common questions
What is Epidiolex used for?
Does Epidiolex interact with other seizure medications?
Read the original research
Emerging Use of Epidiolex (Cannabidiol) in Epilepsy.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 25(6), 485-499
Citation
Abu-Sawwa, Renad; Scutt, Brielle; Park, Yong. (2020). Emerging Use of Epidiolex (Cannabidiol) in Epilepsy.. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 25(6), 485-499. https://doi.org/10.5863/1551-6776-25.6.485
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk